<DOC>
	<DOCNO>NCT00638391</DOCNO>
	<brief_summary>The purpose study initial/followed 5 year adjuvant therapy Anastrozole .</brief_summary>
	<brief_title>Ax-003/Arimidex ( Anastrozole ) Adjuvant Therapy Early Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<criteria>Postmenopausal woman early hormone receptor positive breast cancer/no metastasis</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Primary early MCa</keyword>
	<keyword>Arimidex</keyword>
</DOC>